干眼症状与体征不一致的预测因素:来自干燥综合征国际协作临床联盟的见解
本研究利用干燥综合征国际协作临床联盟3455名21至89岁参与者的数据,开展横断面研究,以眼表疾病指数6排序评分与眼表染色评分排序评分之差定义症状与体征不一致,采用多变量逐步线性回归筛选预测因素并建模,最终模型纳入10个预测因素,调整R²为0.35(95%CI 0.32-0.39)。作者认为亚裔血统和使用免疫调节药物者常表现为严重眼部体征而需定期眼科评估,眼部症状伴身体其他部位异常感觉可能提示需进一步检查的系统性疾病。
要点
- 最终模型纳入10个预测因素,调整R²为0.35(95%CI 0.32-0.39)。
- 用药解释结局变异的19%(95%CI 0.17-0.22),病史调整R²为0.18(95%CI 0.15-0.21)。
- 健康相关生活质量贡献16%(95%CI 0.13-0.19),人口学贡献11%(95%CI 0.09-0.13)。
核心结论
- 作者认为亚裔血统和使用免疫调节药物者常表现为严重眼部体征,即使没有成比例的眼部症状也需定期眼科评估。
- 作者认为眼部症状若伴随身体其他部位异常感觉,可能提示需进一步检查和医疗处理的系统性疾病。
研究设计与样本
- 横断面研究,使用干燥综合征国际协作临床联盟3455名21至89岁参与者的数据。
- 以眼表疾病指数6排序评分与眼表染色评分排序评分之差定义干眼症状与体征不一致。
- 采用向后消除法和贝叶斯信息准则的多变量逐步线性回归模型筛选预测因素。
主要发现
- 最终模型保留10个预测因素,包括活力、免疫调节药物、感觉症状和族裔等,调整R²为0.35(95%CI 0.32-0.39)。
- 用药解释结局变异的19%(95%CI 0.17-0.22),病史调整R²为0.18(95%CI 0.15-0.21)。
- 健康相关生活质量贡献16%(95%CI 0.13-0.19),人口学贡献11%(95%CI 0.09-0.13)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The diagnosis and management of dry eye disease (DED) could be complicated by the discordance between DED-related symptoms and signs. We performed a cross-sectional study to investigate the factors of and develop predictive models for the discrepancy in DED symptomatology. METHODS: We used data from 3455 participants, 21 to 89 years old, from the Sjögren's International Collaborative Clinical Alliance study. We performed a multivariable stepwise linear regression model with backward elimination and Bayesian information criteria to select predictors for the discordance in DES symptomatology, which was defined as the difference between the rank score of Ocular Surface Disease Index 6 (OSDI-6) and the rank score of ocular staining score (OSS). RESULTS: Ten predictors, such as "vitality," "immunomodulating drugs," sensory symptoms," and "ethnicity," remained in the final models, achieving an adjusted R2 (aR2) of 0.35 (95% confidence interval [CI], 0.32-0.39). Specifically, medication use explained 19% (95% CI, 0.17-0.22) of the variance in the outcome, followed by medical history (aR2 = 0.18; 95% CI, 0.15-0.21). Health-related quality of life contributed 16% to the variance in the outcome (95% CI, 0.13-0.19), and, last, demographics contributed 11% (95% CI, 0.09-0.13). CONCLUSIONS: Our results suggest that individuals of Asian descent and those using immunomodulating medications often present with severe ocular signs that necessitate regular ophthalmological evaluations, even in the absence of proportionate ocular symptoms. Additionally, ocular symptoms, when accompanied by abnormal sensations in other parts of the body, could indicate systemic conditions that require further investigation and medical care.
引用
- Xiong F, Arnold BF, Lietman TM, et al. Predictors of Discordance Between Dry Eye Symptoms and Signs: Insights From the Sjögren's International Collaborative Clinical Alliance. Invest Ophthalmol Vis Sci. 2024. PMID: 39365264. doi:10.1167/iovs.65.12.3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。